Research & Development

Can Logic-Gating Overcome CAR-T Challenges in Solid Tumors?
Research & Development Can Logic-Gating Overcome CAR-T Challenges in Solid Tumors?

The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical

Kodiak Sciences Eye Drugs Match Eylea in Phase 3 Success
Research & Development Kodiak Sciences Eye Drugs Match Eylea in Phase 3 Success

The relentless cycle of invasive eye injections for wet age-related macular degeneration has long remained the heaviest burden for patients who are struggling to preserve their vision. This central challenge defines the current management of retinal diseases, where the high frequency of treatments

Iran Advances Medical Independence Through Biotech Innovation
Research & Development Iran Advances Medical Independence Through Biotech Innovation

Raw material imports for medicine currently account for $749 million in annual spending, representing more than half of the country's total medicinal foreign-exchange costs. This financial burden has catalyzed a strategic pivot toward domestic biotechnology, as the nation seeks to insulate its

The Evolution and Future of Modern CAR-T Cell Therapy
Research & Development The Evolution and Future of Modern CAR-T Cell Therapy

The core architecture of a chimeric antigen receptor relies on a single-chain variable fragment linked to intracellular signaling components that ignite T cell proliferation. As the pharmaceutical industry entered the second half of the current decade, the shift from experimental novelty to

Can Nanoparticles Protect the Liver From Arsenic Poisoning?
Research & Development Can Nanoparticles Protect the Liver From Arsenic Poisoning?

Environmental contamination continues to threaten global populations, necessitating the development of multi-modal defense systems that can shield vital organs from heavy metals. Arsenic, an odorless and tasteless toxin found in groundwater, remains one of the most pervasive threats to human health

New Oral Therapy Shows Promise for Advanced Endometrial Cancer
Research & Development New Oral Therapy Shows Promise for Advanced Endometrial Cancer

Patients who previously failed treatment with lenvatinib monotherapy showed a renewed response when the drug was paired with the novel experimental agent E7386. This breakthrough in gynecologic oncology represents a turning point for patients facing advanced endometrial cancer after exhausting

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later